Why Controlled Release Is Becoming Essential For Patient-Centric Drug Development

Treatment only works if patients can stay on the regimen, which makes formulation a question of adherence. For small molecule oral solid dose programs, controlled release can flatten the peaks and troughs of immediate-release exposure.

The right mechanism depends on the API: diffusion-controlled matrices, osmotic technologies, and biodegradable polymer systems each have to be matched to solubility, permeability, stability, and pharmacokinetic profile. Paediatric, geriatric, and chronic-illness patients each push design in different directions. Manufacturability and scale-up then decide what reaches commercial supply.

Read how the release mechanism is matched to the API.